SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.

Ahmed ElkharsawiUlrike von ArnimRenate SchmelzCornelia SanderAndreas StallmachNiels TeichJens WalldorfPhilipp Alexander Reuken

Published in: Zeitschrift fur Gastroenterologie (2022)

Vaccination against SARS-CoV-2 is safe in IBD patients. These results may help to reduce fears regarding the vaccination in IBD patients. Our results can help to reduce fears in IBD patients regarding the SARS-CoV-2 vaccine. A close communication between patients and physicians before and after the vaccination may be beneficial.

Keyphrases

sars cov
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
primary care
respiratory syndrome coronavirus
patients with inflammatory bowel disease